Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma.

NCT01279694 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01279694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01279694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma.
Lead sponsor
Nantes University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2010
Completion date
February 28, 2014
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma